| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Parshall B Lynne is a Director at IONS, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 42 sales. Those positions are worth an estimated $4.7M at current prices.
Our model assigns Parshall B Lynne a strong insider score of 74/100, based on 20 past trades. Over a 12-month horizon, 93.3% of those trades were profitable, with an average 12-month return of +24.7%.
Parshall B Lynne's largest disclosed position is in IONS as Director, worth about $4.0M. The recent filings there lean toward selling, a net 246,805 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2020 | IONS Ionis Pharmaceuticals Inc | Director | Sell | 10,000 | $60.00 | $600,000.00 | -14.8% | |
| Nov 25, 2020 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 3,590 | $50.05 | $179,679.50 | -5.1% | |
| Nov 24, 2020 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 3,910 | $50.25 | $196,466.20 | -5.5% | |
| Oct 5, 2020 | CYTK Cytokinetics Inc | Director | Sale+OE | 50,311 | $30.00 | $1,509,330.00 | -100% | |
| Jun 22, 2020 | CYTK Cytokinetics Inc | Director | Sale+OE | 16,510 | $25.00 | $412,750.00 | -100% | |
| Apr 29, 2019 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 50,000 | $75.01 | $3,750,635.00 | -48.7% | |
| Mar 12, 2019 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 8,334 | $75.00 | $625,050.00 | -13.7% | |
| Feb 27, 2019 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 8,333 | $70.00 | $583,310.00 | -13.7% |